OLIN Corp SEC filings OLN
OLIN Corp has 1,006 filings in SEC EDGAR's recent list, going back to Aug 19, 2016. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Mar 20, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 20, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Mar 21, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 20, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Mar 15, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 23, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 24, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 22, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 25, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 25, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 26, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 28, 2017 | Dec 31, 2016 |
Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- OLN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Clayton, MO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 74303
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Balchem Corp BCPC
- Perimeter Solutions, Inc. PRM
- Ingevity Corp NGVT
- Innospec Inc. IOSP
- Chemours Co CC
- Huntsman CORP HUN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.